Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Sonnet BioTherapeutics (SONN) News Today

Sonnet BioTherapeutics logo

SONN Latest News

Hyperliquid Wants $1B to Power Its Next HYPE Token Expansion
Sonnet to Present at the MedInvest Biotech & Pharma Conference
Sonnet Releases Virtual Investor "What This Means" Segment
Sonnet BioTherapeutics advances in cancer trial
Sonnet Biotherapeutics Holdings Inc trading halted, news pending
Sonnet BioTherapeutics announces passing of founder, CEO Pankaj Mohan
Sonnet Announces Release of Corporate Update Video
Sonnet BioTherapeutics completes first safety review of SON-1010
Get Sonnet BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SONN Media Mentions By Week

SONN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SONN
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

SONN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SONN Articles
This Week

0

1

SONN Articles
Average Week

Get the Latest News and Ratings for SONN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:SONN) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners